Veterinary CRO Market Size, Share, Trend | Opportunity by 2027

report image

Veterinary CRO Market to 2027 - Global Analysis and Forecasts by Service Type (Clinical Trials, Toxicology, Market Authorization and Regulatory Support, Others); Application (Pet, Livestock, Wild); Indication (Oncology, Infectious Diseases, Neurology, Others); End-User (Animal Husbandry, Others)

Publication Month: Jan 2020 | Report Code: TIPRE00008083 | No. of Pages: 150 | Category: Medical Device | Status: Published

The veterinary CROs market was valued at US$ 710.81 million in 2018 and it is projected to reach US$ 1,440.15 million by 2027; it is expected to grow at a CAGR of 9.3% from 2019 to 2027.

Veterinary CROs are described as organizations offering services that support the veterinary drug discovery processes in veterinary drug companies. For example, some of the services veterinary CROs offer include market authorization support, regulatory support, support for clinical trials and toxicology studies. The growth of the Veterinary CROs Market is attributed to the increasing prevalence of veterinary diseases, rising animal expenditures and strategic initiatives by key players have been boosting the market over the years. However, dearth of skilled professionals is likely to have a negative impact on the growth of the market in the coming years. On the other hand, increasing number of vaccines and biosimilar development for animals is likely to provide growth opportunity for market players in the coming years.

The Veterinary CROs Market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Veterinary CROs Market

Lucrative Regions for Veterinary CROs in Healthcare Market

Get more information on this report :

Market Insights

Growing Applications of Veterinary CROs in Healthcare to Drive Veterinary CROs Market Growth

The animals are playing important aspect in terms of clinical trials. Veterinary contract research organizations services protect and improve the health, efficiency and marketability of the livestock, animal products and veterinary biologics of our nation by preventing, regulating or removing animal diseases, and by tracking and promoting animal health and productivity. For instance, From January to April 2015, disease reports from countries in North and West Africa, the Middle East, East, South and Southeast Asia mainly included outbreaks of Foot and Mouth Disease (FMD) and H5N1 highly pathogenic avian influenza (HPAI), two major trans-boundary animal diseases that are of global economic concern. Disease like Lumpy Skin Disease (LSD), Foot-and-Mouth Disease, Hemorrhagic Septicemia, Black Quarter, Zoonotic disease events are leading to death of the animals, for the wellbeing of animals the veterinary CROs are taking steps for the clinical trial steps for the veterinary medicines.

Approved animal medicinal products help many farmers around the world avoid animal losses every day. These medicines are helpful for the farmers to take better care of their animals. The rising incidence of veterinary diseases is leading to drive the growth of veterinary CRO marketThe animal health sector is on a growth path, propelled by the rise of pet ownership and a global population hungry for meat and dairy products. The demand for animal husbandries or household pets is rising due to the rise in outsourcing activities by pharmaceutical companies. This trend has been seen as a plan to remain competitive and flexible in a market of exponential growth, sophisticated technologies, and an unstable economic environment. 

Companies generally outsource R&D tasks which include a broad range of activities such as, fundamental research to late-stage development: hit exploration and lead optimization, target validation, genetic engineering, assay development, safety and efficacy tests in animal models, and clinical trials which involve animals. In 2017, the total US pet industry spending was estimated to reach $69.36 billion, up from $66.75 billion in 2016. According to American Pet Products Association's 2019-2020 National Pet Owners Survey, the North American Pet Health Insurance Association (NAPHIA) announced that the U.S. and Canada pet health insurance market posted a combined gross paid premium of 1.42 billion dollars in 2018, up from 1.15 billion dollars in 2017. At the end of 2018, the total number of covered pets hit 2.43 million, up by more than 17 per cent from 2017. Therefore, rise in animal health care expenditure is expected to drive the veterinary CRO market during forecast period.

A rise in strategic initiatives by pharmaceutical companies has been witnessed during recent years. This trend has been seen as a plan to remain competitive and flexible in a market of exponential growth, collaboration, acquisition and partnerships, tests in animal models, and clinical trials which involve animal health. These merger and consolidation events typically introduce corporate cost-cutting measures that can be brutal on R&D budgets.

For instance, In August 2018, Charles River Acquired MPI Research premier non-clinical contract research organization (CRO) providing comprehensive testing services to biopharmaceutical and medical device companies. This acquisition will include Ocular toxicology, Infectious disease models for vaccine safety and efficacy studies for development of veterinary safety data assessment. In 2019, Charles River acquired Citoxlab is a premier, non-clinical contract research organization (CRO). Other than this the organizations have taken the initiative of product launch too, for instance, In June 2016, In June, the AVMA launched the AVMA Animal Health Research Database as a tool for researchers searching for animals to engage in clinical studies and for veterinarians and animal owners to discuss treatment options This acquisition will provide the drug discovery and development continuum of drug. This will lead to enhance the veterinary data safety business.

Service Type-Based Insights

In terms of service type, the Veterinary CROs Market is segmented into clinical trials, toxicology, market authorization and regulatory support, others. The clinical trials segment held a largest share of the market in 2019.

Veterinary CROs Market, by Service Type – 2018 and 2027

Veterinary CROs in Healthcare Market, by Service Type – 2018 and 2027

Get more information on this report :

Application-Based Insights

Based on application, the Veterinary CROs Market is segmented into pet, livestock, wild. In 2019, the pet segment held the largest share of the market, by application.

Indication-Based Insights

In terms of indication, the Veterinary CROs Market is segmented into oncology, infectious diseases, neurology, others. In 2019, the oncology segment held the largest share of the market, by indication.

End User-Based Insights

In terms of end user, the Veterinary CROs Market is segmented into pharmaceutical companies, and others. In 2019, the biopharmaceutical segment held the largest share of the market, by end user.

Strategic Insights

Report Coverage - Veterinary CRO Market
Report CoverageDetails
Market Size Value inUS$ 710.81 Million in 2018
Market Size Value byUS$ 1,440.15 Million by 2027
Growth rateCAGR of 9.3% from 2019-2027
Forecast Period2019-2027
Base Year2019
No. of Pages150
No. of Tables99
No. of Charts & Figures67
Historical data availableYes
Segments coveredService Type ; Application ; Indication ; End-User
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

The Veterinary CROs Market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Veterinary CROs Market – by Service Type

  • Clinical Trials
  • Toxicology
  • Market Authorization and Regulatory Support
  • Others

Veterinary CROs Market – by Application

  • Pet
  • Livestock
  • Wild

Veterinary CROs Market – by Indication

  • Oncology
  • Infectious Diseases
  • Neurology
  • Others

Veterinary CROs Market – by End User

  • Biopharmaceutical Companies
  • Others

Veterinary CROs Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Charles River
  • Clinvet
  • Löhlein & Wolf Vet Research
  • Oncovet Clinical Research
  • Ondax Scientific
  • Triveritas
  • Veterinary Research Management
  • VetPharm, Inc.
  • Vetspin Srl

Frequently Asked Questions

Veterinary CROs are described as organizations offering services that support the veterinary drug discovery processes in veterinary drug companies. For example, some of the services veterinary CROs offer include market authorization support, regulatory support, support for clinical trials and toxicology studies.
Driving factors such as rising prevalence of veterinary diseases across the globe and Increasing animal healthcare expenditure are expected to boost the market growth over the years. Moreover, development of biosimilar and vaccines for animals is likely to have a positive impact on the growth of the market in the coming years.
The Indications covered in veterinary CROs services are oncology, gastrointestinal diseases, Infectious Diseases and Neurology.

The List of Companies - Veterinary CROs Market

  1. Charles River Laboratories, Inc.
  2. Clinvet
  3. Klifovet ag
  4. Löhlein and Wolf Vet Research
  5. Oncovet Clinical Research
  6. Ondax Scientific
  7. Triveritas
  8. Research Management (Vrm) Ltd
  9. Vetpharm, Inc.
  10. Vetspin Srl
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Veterinary CROs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Veterinary CROs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount